| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZBTB9 ZBTB40 ZNF536 ZEB1 ZNF148 PRDM15 ATF2 ZEB2 ZNF451 ZBTB14 ZFX ZFY ZNF404 ZNF516 ZNF304 | 8.56e-12 | 1412 | 25 | 15 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZBTB9 ZNF536 ZEB1 ZNF148 PRDM15 ATF2 TOP1 ZEB2 ZBTB14 ZFX ZFY ZNF404 ZNF516 ZNF304 | 2.41e-10 | 1459 | 25 | 14 | GO:0000977 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZBTB9 ZNF536 ZEB1 ZNF148 PRDM15 ATF2 TOP1 ZEB2 ZBTB14 ZFX ZFY ZNF516 ZNF304 | 5.15e-10 | 1244 | 25 | 13 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZBTB9 ZNF536 ZEB1 ZNF148 PRDM15 ATF2 TOP1 ZEB2 ZBTB14 ZFX ZFY ZNF516 ZNF304 | 6.71e-10 | 1271 | 25 | 13 | GO:0000987 |
| GeneOntologyMolecularFunction | chromatin binding | 2.09e-06 | 739 | 25 | 8 | GO:0003682 | |
| GeneOntologyMolecularFunction | chromatin insulator sequence binding | 3.15e-05 | 7 | 25 | 2 | GO:0043035 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 4.18e-05 | 320 | 25 | 5 | GO:0001227 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 4.57e-05 | 326 | 25 | 5 | GO:0001217 | |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 1.49e-04 | 83 | 25 | 3 | GO:1990841 | |
| GeneOntologyMolecularFunction | N-acyltransferase activity | 2.74e-04 | 102 | 25 | 3 | GO:0016410 | |
| GeneOntologyMolecularFunction | histone H4 acetyltransferase activity | 3.75e-04 | 23 | 25 | 2 | GO:0010485 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 5.68e-04 | 560 | 25 | 5 | GO:0001228 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 5.97e-04 | 566 | 25 | 5 | GO:0001216 | |
| GeneOntologyMolecularFunction | chromatin DNA binding | 1.15e-03 | 167 | 25 | 3 | GO:0031490 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 1.85e-03 | 51 | 25 | 2 | GO:0004402 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 2.15e-03 | 55 | 25 | 2 | GO:0061733 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 2.55e-03 | 60 | 25 | 2 | GO:0034212 | |
| GeneOntologyMolecularFunction | histone modifying activity | 2.84e-03 | 229 | 25 | 3 | GO:0140993 | |
| GeneOntologyMolecularFunction | acyltransferase activity, transferring groups other than amino-acyl groups | 3.17e-03 | 238 | 25 | 3 | GO:0016747 | |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 4.26e-03 | 78 | 25 | 2 | GO:0008080 | |
| GeneOntologyMolecularFunction | acetyltransferase activity | 7.45e-03 | 104 | 25 | 2 | GO:0016407 | |
| GeneOntologyMolecularFunction | acyltransferase activity | 1.49e-02 | 775 | 25 | 4 | GO:0016746 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | 2.40e-06 | 1390 | 25 | 10 | GO:0045944 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | 2.23e-05 | 1053 | 25 | 8 | GO:0000122 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | 1.67e-04 | 1399 | 25 | 8 | GO:0045892 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | 1.79e-04 | 1413 | 25 | 8 | GO:1902679 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | 2.08e-04 | 741 | 25 | 6 | GO:0006338 | |
| GeneOntologyBiologicalProcess | parental behavior | 2.92e-04 | 21 | 25 | 2 | GO:0060746 | |
| GeneOntologyBiologicalProcess | post-embryonic development | 5.68e-04 | 135 | 25 | 3 | GO:0009791 | |
| GeneOntologyBiologicalProcess | chromatin organization | 5.75e-04 | 896 | 25 | 6 | GO:0006325 | |
| Domain | ZINC_FINGER_C2H2_2 | ZBTB9 ZBTB40 ZNF407 ZNF536 ZEB1 ZNF148 PRDM15 ATF2 ZEB2 ZNF451 ZBTB14 BRPF1 ZFX ZFY ZNF404 ZNF516 ZNF304 | 7.12e-19 | 775 | 24 | 17 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZBTB9 ZBTB40 ZNF407 ZNF536 ZEB1 ZNF148 PRDM15 ATF2 ZEB2 ZNF451 ZBTB14 BRPF1 ZFX ZFY ZNF404 ZNF516 ZNF304 | 7.44e-19 | 777 | 24 | 17 | PS00028 |
| Domain | Znf_C2H2-like | ZBTB9 ZBTB40 ZNF407 ZNF536 ZEB1 ZNF148 PRDM15 ATF2 ZEB2 ZNF451 ZBTB14 BRPF1 ZFX ZFY ZNF404 ZNF516 ZNF304 | 1.12e-18 | 796 | 24 | 17 | IPR015880 |
| Domain | Znf_C2H2 | ZBTB9 ZBTB40 ZNF407 ZNF536 ZEB1 ZNF148 PRDM15 ATF2 ZEB2 ZNF451 ZBTB14 BRPF1 ZFX ZFY ZNF404 ZNF516 ZNF304 | 1.35e-18 | 805 | 24 | 17 | IPR007087 |
| Domain | ZnF_C2H2 | ZBTB9 ZBTB40 ZNF407 ZNF536 ZEB1 ZNF148 PRDM15 ATF2 ZEB2 ZNF451 ZBTB14 BRPF1 ZFX ZFY ZNF404 ZNF516 ZNF304 | 1.44e-18 | 808 | 24 | 17 | SM00355 |
| Domain | - | ZBTB9 ZBTB40 ZNF407 ZNF536 ZEB1 ZNF148 PRDM15 ATF2 ZEB2 ZBTB14 ZFX ZFY ZNF404 ZNF516 ZNF304 | 2.12e-16 | 679 | 24 | 15 | 3.30.160.60 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZBTB9 ZBTB40 ZNF407 ZNF536 ZEB1 ZNF148 PRDM15 ATF2 ZEB2 ZBTB14 ZFX ZFY ZNF404 ZNF516 ZNF304 | 2.94e-16 | 694 | 24 | 15 | IPR013087 |
| Domain | zf-C2H2 | ZBTB9 ZBTB40 ZNF407 ZNF536 ZNF148 PRDM15 ATF2 ZNF451 ZBTB14 ZFX ZFY ZNF404 ZNF516 ZNF304 | 1.15e-14 | 693 | 24 | 14 | PF00096 |
| Domain | Zfx_Zfy_act | 4.74e-06 | 3 | 24 | 2 | PF04704 | |
| Domain | Transcrp_activ_Zfx/Zfy-dom | 4.74e-06 | 3 | 24 | 2 | IPR006794 | |
| Domain | Di19_Zn_binding_dom | 3.31e-05 | 7 | 24 | 2 | IPR008598 | |
| Domain | zf-Di19 | 3.31e-05 | 7 | 24 | 2 | PF05605 | |
| Domain | BTB | 6.13e-04 | 131 | 24 | 3 | PF00651 | |
| Domain | BROMODOMAIN_1 | 1.03e-03 | 37 | 24 | 2 | PS00633 | |
| Domain | Bromodomain | 1.08e-03 | 38 | 24 | 2 | PF00439 | |
| Domain | BTB | 1.09e-03 | 160 | 24 | 3 | PS50097 | |
| Domain | BROMODOMAIN_2 | 1.26e-03 | 41 | 24 | 2 | PS50014 | |
| Domain | BROMO | 1.32e-03 | 42 | 24 | 2 | SM00297 | |
| Domain | Bromodomain | 1.32e-03 | 42 | 24 | 2 | IPR001487 | |
| Domain | - | 1.32e-03 | 42 | 24 | 2 | 1.20.920.10 | |
| Domain | BTB | 1.54e-03 | 180 | 24 | 3 | SM00225 | |
| Domain | SET | 1.58e-03 | 46 | 24 | 2 | SM00317 | |
| Domain | BTB/POZ_dom | 1.66e-03 | 185 | 24 | 3 | IPR000210 | |
| Domain | SKP1/BTB/POZ | 1.77e-03 | 189 | 24 | 3 | IPR011333 | |
| Domain | SET_dom | 1.87e-03 | 50 | 24 | 2 | IPR001214 | |
| Domain | SET | 1.87e-03 | 50 | 24 | 2 | PS50280 | |
| Domain | Zinc_finger_PHD-type_CS | 3.13e-03 | 65 | 24 | 2 | IPR019786 | |
| Domain | Znf_PHD-finger | 4.59e-03 | 79 | 24 | 2 | IPR019787 | |
| Domain | PHD | 5.79e-03 | 89 | 24 | 2 | SM00249 | |
| Domain | Znf_PHD | 6.04e-03 | 91 | 24 | 2 | IPR001965 | |
| Domain | ZF_PHD_2 | 6.57e-03 | 95 | 24 | 2 | PS50016 | |
| Domain | ZF_PHD_1 | 6.70e-03 | 96 | 24 | 2 | PS01359 | |
| Domain | Znf_FYVE_PHD | 1.52e-02 | 147 | 24 | 2 | IPR011011 | |
| Domain | HOMEOBOX_1 | 3.66e-02 | 236 | 24 | 2 | PS00027 | |
| Domain | HOX | 3.68e-02 | 237 | 24 | 2 | SM00389 | |
| Pubmed | 3.28e-09 | 5 | 25 | 3 | 9244432 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 4.13e-09 | 351 | 25 | 7 | 38297188 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 6.94e-09 | 608 | 25 | 8 | 36089195 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | 7.60e-09 | 908 | 25 | 9 | 19274049 | |
| Pubmed | ZBTB9 ZBTB40 ZNF536 ZEB1 ZNF148 TOP1 ZEB2 ZNF451 ZBTB14 ZNF516 | 2.47e-08 | 1429 | 25 | 10 | 35140242 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | 1.17e-07 | 877 | 25 | 8 | 20211142 | |
| Pubmed | 4.24e-07 | 418 | 25 | 6 | 34709266 | ||
| Pubmed | The Zeb proteins δEF1 and Sip1 may have distinct functions in lens cells following cataract surgery. | 4.96e-07 | 2 | 25 | 2 | 25082886 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 37948583 | ||
| Pubmed | ZEBs: Novel Players in Immune Cell Development and Function. | 4.96e-07 | 2 | 25 | 2 | 30956067 | |
| Pubmed | The mesodermal and myogenic specification of hESCs depend on ZEB1 and are inhibited by ZEB2. | 4.96e-07 | 2 | 25 | 2 | 37819755 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 2308929 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 28416756 | ||
| Pubmed | Mapping the human ZFX locus to Xp21.3 by in situ hybridization. | 4.96e-07 | 2 | 25 | 2 | 2497060 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 28251288 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 12716983 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 28133913 | ||
| Pubmed | Intron/exon structure confirms that mouse Zfy1 and Zfy2 are members of the ZFY gene family. | 4.96e-07 | 2 | 25 | 2 | 9126493 | |
| Pubmed | Comparison of ZFY and ZFX gene structure and analysis of alternative 3' untranslated regions of ZFY. | 4.96e-07 | 2 | 25 | 2 | 2041734 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 20025777 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 20424117 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 8318216 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 2105457 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 12609600 | ||
| Pubmed | Transcription factor Zfx controls BCR-induced proliferation and survival of B lymphocytes. | 4.96e-07 | 2 | 25 | 2 | 19329779 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 24306957 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 34324278 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 20375168 | ||
| Pubmed | Prognostic Significance of Zinc Finger E-Box-Binding Homeobox Family in Glioblastoma. | 4.96e-07 | 2 | 25 | 2 | 29476046 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 22213144 | ||
| Pubmed | Zfx mutation results in small animal size and reduced germ cell number in male and female mice. | 4.96e-07 | 2 | 25 | 2 | 9187153 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 21747944 | ||
| Pubmed | Chromosomal localization of ZFX--a human gene that escapes X inactivation--and its murine homologs. | 4.96e-07 | 2 | 25 | 2 | 1970799 | |
| Pubmed | Evolution of the Zfx and Zfy genes: rates and interdependence between the genes. | 4.96e-07 | 2 | 25 | 2 | 8487630 | |
| Pubmed | Functional conservation of zinc-finger homeodomain gene zfh1/SIP1 in Drosophila heart development. | 4.96e-07 | 2 | 25 | 2 | 16957952 | |
| Pubmed | [Expression of Zfx in mouse testicular spermatogenic cells]. | 4.96e-07 | 2 | 25 | 2 | 38602753 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 34550965 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 22892238 | ||
| Pubmed | Zfa is an expressed retroposon derived from an alternative transcript of the Zfx gene. | 4.96e-07 | 2 | 25 | 2 | 1691708 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 2265557 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 8188262 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 8.92e-07 | 774 | 25 | 7 | 15302935 | |
| Pubmed | 1.19e-06 | 808 | 25 | 7 | 20412781 | ||
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 26823172 | ||
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 23412770 | ||
| Pubmed | A miRNA signature associated with human metastatic medullary thyroid carcinoma. | 1.49e-06 | 3 | 25 | 2 | 24127332 | |
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 21890822 | ||
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 18376396 | ||
| Pubmed | TCF4 promotes colorectal cancer drug resistance and stemness via regulating ZEB1/ZEB2 expression. | 1.49e-06 | 3 | 25 | 2 | 31933004 | |
| Pubmed | p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. | 1.49e-06 | 3 | 25 | 2 | 21518799 | |
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 18411277 | ||
| Pubmed | miR-139-5p suppresses cancer cell migration and invasion through targeting ZEB1 and ZEB2 in GBM. | 1.49e-06 | 3 | 25 | 2 | 25833697 | |
| Pubmed | Down-regulation of miR-144 promotes thyroid cancer cell invasion by targeting ZEB1 and ZEB2. | 1.49e-06 | 3 | 25 | 2 | 24968735 | |
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 29052277 | ||
| Pubmed | Expression of miR-9 and miR-200c, ZEB1, ZEB2 and E-cadherin in Non-Small Cell Lung Cancers in Iran. | 1.49e-06 | 3 | 25 | 2 | 31244281 | |
| Pubmed | YAC clone contigs surrounding the Zfx and Pola loci on the mouse X chromosome. | 1.49e-06 | 3 | 25 | 2 | 8406471 | |
| Pubmed | Zfy gene expression patterns are not compatible with a primary role in mouse sex determination. | 1.49e-06 | 3 | 25 | 2 | 2480529 | |
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 34226299 | ||
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 26022123 | ||
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 21411626 | ||
| Pubmed | BMP4 signaling mediates Zeb family in developing mouse tooth. | 1.49e-06 | 3 | 25 | 2 | 22350174 | |
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 11299520 | ||
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 12479614 | ||
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 17615296 | ||
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 24165969 | ||
| Pubmed | Isolation of monochromosomal hybrids for mouse chromosomes 3, 6, 10, 12, 14, and 18. | 1.49e-06 | 3 | 25 | 2 | 9060403 | |
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 26556542 | ||
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 38310188 | ||
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 32406922 | ||
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 29302045 | ||
| Pubmed | 1.60e-06 | 32 | 25 | 3 | 27806288 | ||
| Pubmed | ZFX controls propagation and prevents differentiation of acute T-lymphoblastic and myeloid leukemia. | 2.97e-06 | 4 | 25 | 2 | 24485662 | |
| Pubmed | Fra-1/AP-1 induces EMT in mammary epithelial cells by modulating Zeb1/2 and TGFβ expression. | 2.97e-06 | 4 | 25 | 2 | 25301070 | |
| Pubmed | 2.97e-06 | 4 | 25 | 2 | 28247944 | ||
| Pubmed | 2.97e-06 | 4 | 25 | 2 | 16598713 | ||
| Pubmed | miR-200b regulates cell migration via Zeb family during mouse palate development. | 2.97e-06 | 4 | 25 | 2 | 22261924 | |
| Pubmed | 2.97e-06 | 4 | 25 | 2 | 31679088 | ||
| Pubmed | 2.97e-06 | 4 | 25 | 2 | 17360662 | ||
| Pubmed | 2.97e-06 | 4 | 25 | 2 | 29200203 | ||
| Pubmed | 2.97e-06 | 4 | 25 | 2 | 21079000 | ||
| Pubmed | The MicroRNA 29 Family Promotes Type II Cell Differentiation in Developing Lung. | 2.97e-06 | 4 | 25 | 2 | 27215389 | |
| Pubmed | 2.97e-06 | 4 | 25 | 2 | 23381389 | ||
| Pubmed | Zfx controls the self-renewal of embryonic and hematopoietic stem cells. | 2.97e-06 | 4 | 25 | 2 | 17448993 | |
| Pubmed | Chromosome mapping and expression of a putative testis-determining gene in mouse. | 4.95e-06 | 5 | 25 | 2 | 2563174 | |
| Pubmed | 4.95e-06 | 5 | 25 | 2 | 9721210 | ||
| Pubmed | 4.95e-06 | 5 | 25 | 2 | 18829540 | ||
| Pubmed | Maintenance of X inactivation of the Rps4, Zfx, and Ube1 genes in a mouse in vitro system. | 4.95e-06 | 5 | 25 | 2 | 7681608 | |
| Pubmed | ZEB1, ZEB2, and the miR-200 family form a counterregulatory network to regulate CD8+ T cell fates. | 4.95e-06 | 5 | 25 | 2 | 29449309 | |
| Pubmed | 4.95e-06 | 5 | 25 | 2 | 12743039 | ||
| Pubmed | Opposing functions of ZEB proteins in the regulation of the TGFbeta/BMP signaling pathway. | 4.95e-06 | 5 | 25 | 2 | 12743038 | |
| Pubmed | Zfx facilitates tumorigenesis caused by activation of the Hedgehog pathway. | 4.95e-06 | 5 | 25 | 2 | 25164012 | |
| Pubmed | A developmentally regulated inducer of EMT, LBX1, contributes to breast cancer progression. | 4.95e-06 | 5 | 25 | 2 | 19651985 | |
| Pubmed | 7.43e-06 | 6 | 25 | 2 | 7821804 | ||
| Pubmed | 7.43e-06 | 6 | 25 | 2 | 22685266 | ||
| Pubmed | 7.43e-06 | 6 | 25 | 2 | 12161443 | ||
| Pubmed | 8.94e-06 | 709 | 25 | 6 | 22988430 | ||
| Pubmed | 9.22e-06 | 1103 | 25 | 7 | 34189442 | ||
| Pubmed | An evaluation of the inactive mouse X chromosome in somatic cell hybrids. | 1.04e-05 | 7 | 25 | 2 | 8460399 | |
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 8378320 | ||
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 7928394 | ||
| Interaction | KLF12 interactions | 2.85e-09 | 194 | 25 | 7 | int:KLF12 | |
| Interaction | KLF3 interactions | 8.75e-09 | 228 | 25 | 7 | int:KLF3 | |
| Interaction | TEAD1 interactions | 6.29e-08 | 176 | 25 | 6 | int:TEAD1 | |
| Interaction | H3-3A interactions | 1.54e-07 | 749 | 25 | 9 | int:H3-3A | |
| Interaction | EN1 interactions | 2.15e-07 | 110 | 25 | 5 | int:EN1 | |
| Interaction | ZFY interactions | 3.68e-07 | 12 | 25 | 3 | int:ZFY | |
| Interaction | MYB interactions | 5.55e-07 | 133 | 25 | 5 | int:MYB | |
| Interaction | LHX6 interactions | 7.47e-07 | 58 | 25 | 4 | int:LHX6 | |
| Interaction | GATA2 interactions | 4.04e-06 | 199 | 25 | 5 | int:GATA2 | |
| Interaction | PAX6 interactions | 4.55e-06 | 366 | 25 | 6 | int:PAX6 | |
| Interaction | CENPA interactions | 5.40e-06 | 377 | 25 | 6 | int:CENPA | |
| Interaction | NFIX interactions | 7.67e-06 | 227 | 25 | 5 | int:NFIX | |
| Interaction | ELK3 interactions | 1.37e-05 | 120 | 25 | 4 | int:ELK3 | |
| Interaction | ZNF330 interactions | 1.41e-05 | 446 | 25 | 6 | int:ZNF330 | |
| Interaction | H3C3 interactions | 2.54e-05 | 495 | 25 | 6 | int:H3C3 | |
| Interaction | ADAMTS16 interactions | 3.09e-05 | 7 | 25 | 2 | int:ADAMTS16 | |
| Interaction | SP7 interactions | 3.13e-05 | 304 | 25 | 5 | int:SP7 | |
| Interaction | KLF8 interactions | 4.57e-05 | 329 | 25 | 5 | int:KLF8 | |
| Interaction | NFATC1 interactions | 5.14e-05 | 168 | 25 | 4 | int:NFATC1 | |
| Interaction | EGR2 interactions | 5.51e-05 | 171 | 25 | 4 | int:EGR2 | |
| Interaction | FEV interactions | 1.07e-04 | 203 | 25 | 4 | int:FEV | |
| Interaction | ZNF407 interactions | 1.33e-04 | 14 | 25 | 2 | int:ZNF407 | |
| Interaction | GSC interactions | 1.67e-04 | 87 | 25 | 3 | int:GSC | |
| Interaction | MPHOSPH8 interactions | 2.03e-04 | 93 | 25 | 3 | int:MPHOSPH8 | |
| Interaction | POLR1G interactions | 2.93e-04 | 489 | 25 | 5 | int:POLR1G | |
| Interaction | HNF4A interactions | 3.42e-04 | 275 | 25 | 4 | int:HNF4A | |
| Interaction | TBXT interactions | 3.90e-04 | 116 | 25 | 3 | int:TBXT | |
| Interaction | ZBTB9 interactions | 4.00e-04 | 117 | 25 | 3 | int:ZBTB9 | |
| Interaction | ZFX interactions | 4.01e-04 | 24 | 25 | 2 | int:ZFX | |
| Interaction | COIL interactions | 5.11e-04 | 552 | 25 | 5 | int:COIL | |
| Interaction | USP35 interactions | 5.48e-04 | 28 | 25 | 2 | int:USP35 | |
| Interaction | CEBPA interactions | 6.06e-04 | 1245 | 25 | 7 | int:CEBPA | |
| Interaction | H2BC8 interactions | 6.20e-04 | 576 | 25 | 5 | int:H2BC8 | |
| Interaction | APEX1 interactions | 6.85e-04 | 1271 | 25 | 7 | int:APEX1 | |
| Interaction | ATM interactions | 7.04e-04 | 333 | 25 | 4 | int:ATM | |
| Interaction | FBXO38 interactions | 7.47e-04 | 145 | 25 | 3 | int:FBXO38 | |
| Interaction | PHF21A interactions | 7.86e-04 | 343 | 25 | 4 | int:PHF21A | |
| Interaction | KDM1A interactions | 8.41e-04 | 941 | 25 | 6 | int:KDM1A | |
| Interaction | ELF2 interactions | 9.23e-04 | 156 | 25 | 3 | int:ELF2 | |
| Interaction | FBLN5 interactions | 9.76e-04 | 159 | 25 | 3 | int:FBLN5 | |
| Interaction | ZBTB7B interactions | 1.00e-03 | 366 | 25 | 4 | int:ZBTB7B | |
| Interaction | UBE2I interactions | 1.10e-03 | 654 | 25 | 5 | int:UBE2I | |
| Cytoband | 18q23 | 1.15e-04 | 29 | 25 | 2 | 18q23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr18p11 | 5.83e-03 | 210 | 25 | 2 | chr18p11 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZBTB9 ZBTB40 ZNF407 ZNF536 ZEB1 ZNF148 PRDM15 ZEB2 ZNF451 ZBTB14 ZFX ZFY ZNF404 ZNF516 ZNF304 | 3.63e-17 | 718 | 21 | 15 | 28 |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.34e-04 | 15 | 21 | 2 | 529 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 4.80e-04 | 134 | 21 | 3 | 861 | |
| GeneFamily | PHD finger proteins | 4.84e-03 | 90 | 21 | 2 | 88 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | 2.57e-05 | 790 | 25 | 7 | gudmap_developingGonad_e16.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.77e-05 | 151 | 25 | 4 | gudmap_developingLowerUrinaryTract_P1_ureter_1000_k4 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | 2.81e-05 | 801 | 25 | 7 | gudmap_developingGonad_e14.5_ epididymis_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#4_top-relative-expression-ranked_500 | 1.86e-04 | 247 | 25 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500_k4 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.24e-04 | 259 | 25 | 4 | gudmap_developingGonad_e12.5_epididymis_k3_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.37e-04 | 492 | 25 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | 2.76e-04 | 804 | 25 | 6 | gudmap_developingGonad_e12.5_ovary_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.81e-04 | 275 | 25 | 4 | gudmap_developingGonad_e14.5_ epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.89e-04 | 277 | 25 | 4 | gudmap_developingGonad_e12.5_ovary_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | 2.97e-04 | 815 | 25 | 6 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.18e-04 | 284 | 25 | 4 | gudmap_developingGonad_e16.5_epididymis_1000_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#3 | 4.64e-04 | 314 | 25 | 4 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K3 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.16e-04 | 323 | 25 | 4 | gudmap_developingGonad_e11.5_ovary + mesonephros_k2_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_500 | 7.09e-04 | 150 | 25 | 3 | gudmap_developingGonad_e12.5_epididymis_k5_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#4_top-relative-expression-ranked_500 | 7.37e-04 | 152 | 25 | 3 | gudmap_developingGonad_e18.5_epididymis_500_k4 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_500 | 8.70e-04 | 161 | 25 | 3 | gudmap_developingGonad_e12.5_ovary_k3_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_500 | 8.86e-04 | 162 | 25 | 3 | gudmap_developingGonad_e16.5_epididymis_500_k2 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_500 | 1.05e-03 | 172 | 25 | 3 | gudmap_developingGonad_e11.5_ovary + mesonephros_k4_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500 | 1.18e-03 | 403 | 25 | 4 | gudmap_developingGonad_e12.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_500 | 1.19e-03 | 404 | 25 | 4 | gudmap_developingGonad_e18.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | 1.21e-03 | 406 | 25 | 4 | gudmap_developingGonad_e16.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_500 | 1.25e-03 | 409 | 25 | 4 | gudmap_developingGonad_e12.5_ovary_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | 1.29e-03 | 413 | 25 | 4 | gudmap_developingGonad_e14.5_ epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_500 | 1.34e-03 | 417 | 25 | 4 | gudmap_developingGonad_e11.5_ovary + mesonephros_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_500 | 1.48e-03 | 429 | 25 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500 | |
| ToppCell | Control-PLT_4|Control / Disease Group and Platelet Clusters | 4.28e-06 | 198 | 25 | 4 | 387fd3037fd52e4d4c42de0588767e58af228b59 | |
| ToppCell | Control-PLT_4|World / Disease Group and Platelet Clusters | 8.56e-05 | 154 | 25 | 3 | a2a03c5e6759c45aeeedf1e68ecb5a0112ef9a20 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.29e-04 | 177 | 25 | 3 | 68f1139fc378f351e3b9e9f392aacb150025bf03 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-04 | 185 | 25 | 3 | 51dfe6ac7df8b330343b37e3bee71e5c65267189 | |
| ToppCell | BAL-Mild-cDC_12|Mild / Compartment, Disease Groups and Clusters | 1.47e-04 | 185 | 25 | 3 | e867ed55ab0df018f14bca824da09d36d83e12f9 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-04 | 185 | 25 | 3 | a8c02cec3c414f3a0da9f2d6d28ce563b0030705 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.50e-04 | 186 | 25 | 3 | 7def03dd856b765bd3f493288641981c4f7fd26e | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 1.50e-04 | 186 | 25 | 3 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.54e-04 | 188 | 25 | 3 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | COVID-19_Mild-PLT_4|World / Disease Group and Platelet Clusters | 1.67e-04 | 193 | 25 | 3 | 98a52523aa1efd5d14a2878ed106828a80a33aa2 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Neuronal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.74e-04 | 196 | 25 | 3 | e874aa82a20bb59582c8cd7f8d30b2ed02903a85 | |
| ToppCell | 3'-Adult-LargeIntestine-Neuronal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.80e-04 | 198 | 25 | 3 | 2488ea95003f218afb25ecc873805b825e6cc409 | |
| ToppCell | 3'-Adult-LargeIntestine-Neuronal-Glial_mature|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.80e-04 | 198 | 25 | 3 | 98ab27335d126fa7817a46953948e524d91248f8 | |
| ToppCell | 3'-Adult-LargeIntestine-Neuronal-Glial_mature-Adult_Glia|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.80e-04 | 198 | 25 | 3 | 991db02a76f7506848827601e927cf997cb520d3 | |
| ToppCell | COVID-19_Mild-PLT_4|COVID-19_Mild / Disease Group and Platelet Clusters | 1.80e-04 | 198 | 25 | 3 | 3d8c33dba759df0974aeb2b9a6b5167ae7a18e1f | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.82e-04 | 199 | 25 | 3 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast-(8)_Fibroblasts|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.82e-04 | 199 | 25 | 3 | 615f20bf136dfef53b072667cf0e4df6a1017e05 | |
| ToppCell | Macroglial-Oligodendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.85e-04 | 200 | 25 | 3 | 4dbac2f2587e87ca5a0622f50439bb5447e93c7f | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.85e-04 | 200 | 25 | 3 | 272909f4354f3ae22e2b2f8f35970e6b0e92cfe2 | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.85e-04 | 200 | 25 | 3 | 26b989e30bbbaf30904ced03f6aae3dea25c732c | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.85e-04 | 200 | 25 | 3 | 1314664c1721e9ecb1e2c3482a039044b0fe50a9 | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.85e-04 | 200 | 25 | 3 | 5f75a9b8bcd49d9bbb1e9ce2de730eaec96369ca | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.85e-04 | 200 | 25 | 3 | 8b229f095fc113aecfc94b64862a9e0fdcc363ce | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.85e-04 | 200 | 25 | 3 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| Computational | Genes in the cancer module 123. | 5.12e-04 | 247 | 17 | 4 | MODULE_123 | |
| Computational | Neighborhood of TNFRSF6 | 2.13e-03 | 167 | 17 | 3 | MORF_TNFRSF6 | |
| Computational | Neighborhood of PPP2R5B | 2.36e-03 | 173 | 17 | 3 | MORF_PPP2R5B | |
| Computational | Neighborhood of DMPK | 2.44e-03 | 175 | 17 | 3 | MORF_DMPK | |
| Computational | Neighborhood of PRKCA | 2.68e-03 | 181 | 17 | 3 | MORF_PRKCA | |
| Computational | Neighborhood of MAP2K7 | 2.68e-03 | 181 | 17 | 3 | MORF_MAP2K7 | |
| Computational | Neighborhood of CTSB | 2.94e-03 | 187 | 17 | 3 | MORF_CTSB | |
| Computational | Neighborhood of PTPRD | 3.69e-03 | 58 | 17 | 2 | GCM_PTPRD | |
| Computational | Neighborhood of IFNA1 | 3.82e-03 | 205 | 17 | 3 | MORF_IFNA1 | |
| Drug | vinylene | 6.25e-09 | 245 | 25 | 7 | CID000006326 | |
| Disease | Disease Exacerbation | 9.18e-06 | 165 | 24 | 4 | C0235874 | |
| Disease | Malignant neoplasm of breast | 1.67e-05 | 1074 | 24 | 7 | C0006142 | |
| Disease | rheumatic heart disease (biomarker_via_orthology) | 4.16e-05 | 12 | 24 | 2 | DOID:0050827 (biomarker_via_orthology) | |
| Disease | Familial Nonmedullary Thyroid Cancer | 1.13e-03 | 61 | 24 | 2 | C3501844 | |
| Disease | Nonmedullary Thyroid Carcinoma | 1.13e-03 | 61 | 24 | 2 | C3501843 | |
| Disease | pyruvate measurement | 1.30e-03 | 268 | 24 | 3 | EFO_0010117 | |
| Disease | Benign Neoplasm | 1.40e-03 | 68 | 24 | 2 | C0086692 | |
| Disease | Neoplasms | 1.40e-03 | 68 | 24 | 2 | C0027651 | |
| Disease | Papillary thyroid carcinoma | 2.22e-03 | 86 | 24 | 2 | C0238463 | |
| Disease | C-reactive protein measurement | 2.51e-03 | 1206 | 24 | 5 | EFO_0004458 | |
| Disease | pathological myopia | 3.67e-03 | 111 | 24 | 2 | EFO_0004207 | |
| Disease | cortical surface area measurement | 4.02e-03 | 1345 | 24 | 5 | EFO_0010736 | |
| Disease | Malignant Neoplasms | 4.84e-03 | 128 | 24 | 2 | C0006826 | |
| Disease | insomnia measurement | 5.38e-03 | 443 | 24 | 3 | EFO_0007876 | |
| Disease | corneal resistance factor | 5.66e-03 | 451 | 24 | 3 | EFO_0010067 | |
| Disease | Neoplastic Cell Transformation | 5.68e-03 | 139 | 24 | 2 | C0007621 | |
| Disease | cataract | 5.84e-03 | 141 | 24 | 2 | MONDO_0005129 | |
| Disease | Malignant neoplasm of liver | 5.92e-03 | 142 | 24 | 2 | C0345904 | |
| Disease | Liver neoplasms | 5.92e-03 | 142 | 24 | 2 | C0023903 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ERYKHKEKHRCHMSC | 1526 | Q9NR48 | |
| HLAVHKHKHEMTLKF | 41 | P15336 | |
| ADMRKVHHCFHHLKK | 416 | Q6ZMV9 | |
| AHKKMHKHQKHHKYH | 116 | Q9NZ81 | |
| KHMRLFIHNHEQHHK | 316 | Q02809 | |
| AFKESQCHHMLKHLH | 46 | Q8J025 | |
| MKTKHALRHHMKLHK | 1121 | P57071 | |
| HKRMDHLKVKKHHCD | 46 | Q1XH10 | |
| HKNKEKRKDSNHHHH | 151 | P55201 | |
| HMKKHRGSFDHGCHI | 266 | Q92618 | |
| FACHMCDKAFKHKSH | 361 | O43829 | |
| VKQHCMSLASHKFHR | 621 | Q9Y4E5 | |
| ICKKAFKHKHHLIEH | 936 | P37275 | |
| FKHKHHLIEHMRLHS | 941 | P37275 | |
| RHMCLHQKIHHGVKP | 256 | Q494X3 | |
| KGHMRKHKDSFEHCC | 361 | O15090 | |
| CNKRFKLKHHLTEHM | 416 | Q96C00 | |
| VAAHKGKKMHQCRHC | 681 | P17010 | |
| AMFLCHWHKHQVKGH | 91 | Q71RH2 | |
| KAFIHLHHLKMHQKF | 286 | Q9HCX3 | |
| LHHLKMHQKFHTGKR | 291 | Q9HCX3 | |
| LKHKRMCHENHDKKL | 271 | Q9UQR1 | |
| VHIAMKHPTKEKHFH | 1431 | Q9C0G0 | |
| ICKKAFKHKHHLIEH | 1031 | O60315 | |
| SHKHKDKHKDREHRH | 21 | P11387 | |
| HKKHIKAEHADMKFH | 1061 | Q9NUA8 | |
| HVAVHKGKKMHQCRH | 676 | P08048 |